(2S,3S,4R,5R)-3,4,5,6-tetrahydroxy-1,2-bis[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-1-one

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: (2S,3S,4R,5R)-3,4,5,6-tetrahydroxy-1,2-bis[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-1-one
• 化学式: C₂₄H₄₂O₂₁
• 分子量: 666.6
• InChiKey: IJJYJBHZHZGKBZ-UNZPIQQRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -8.9
• 重原子数：
  45
• 可旋转键数：
  12
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.96
• 拓扑面积：
  378
• 氢给体数：
  16
• 氢受体数：
  21

文献信息

• Methods for diagnosing, prognosing, and treating parkinsonism
  申请人：Population Bio, Inc.

  公开号：US11008614B2

  公开（公告）日：2021-05-18

  This document provides methods and materials related to genetic variations of neurological disorders. For example, this document provides methods for using such genetic variations to assess susceptibility of developing Parkinson's disease.

  本文件提供与神经系统疾病基因变异有关的方法和材料。例如，本文件提供了利用此类基因变异评估帕金森病易感性的方法。
• METHODS AND COMPOSITIONS FOR DIAGNOSING, PROGNOSING, AND TREATING NEUROLOGICAL CONDITIONS
  申请人：Population Bio, Inc.

  公开号：EP2895621B1

  公开（公告）日：2020-10-21
• Methods and Compositions for Diagnosing, Prognosing, and Treating Neurological Conditions
  申请人：Population Diagnostics, Inc.

  公开号：US20140162933A1

  公开（公告）日：2014-06-12

  This document provides methods and materials related to genetic variations of neurological disorders. For example, this document provides methods for using such genetic variations to assess susceptibility of developing Parkinson's disease.
• US9976180B2
  申请人：——

  公开号：US9976180B2

  公开（公告）日：2018-05-22